Mulhern B - Search Results

1

Evidence on the relationship between PROMIS-29 and EQ-5D: a literature review.

Pan T, Mulhern B, Viney R, Norman R, Tran-Duy A, Hanmer J, Devlin N. Pan T, et al. Among authors: mulhern b. Qual Life Res. 2022 Jan;31(1):79-89. doi: 10.1007/s11136-021-02911-4. Epub 2021 Jun 28. Qual Life Res. 2022. PMID: 34181154 Review.

2

Binary choice health state valuation and mode of administration: head-to-head comparison of online and CAPI.

Mulhern B, Longworth L, Brazier J, Rowen D, Bansback N, Devlin N, Tsuchiya A. Mulhern B, et al. Value Health. 2013 Jan-Feb;16(1):104-13. doi: 10.1016/j.jval.2012.09.001. Value Health. 2013. PMID: 23337221 Free PMC article.

3

Preparatory study for the revaluation of the EQ-5D tariff: methodology report.

Mulhern B, Bansback N, Brazier J, Buckingham K, Cairns J, Devlin N, Dolan P, Hole AR, Kavetsos G, Longworth L, Rowen D, Tsuchiya A. Mulhern B, et al. Health Technol Assess. 2014 Feb;18(12):vii-xxvi, 1-191. doi: 10.3310/hta18120. Health Technol Assess. 2014. PMID: 24568945 Free PMC article.

4

The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes.

Mulhern B, Meadows K. Mulhern B, et al. Health Qual Life Outcomes. 2014 Mar 24;12:42. doi: 10.1186/1477-7525-12-42. Health Qual Life Outcomes. 2014. PMID: 24661350 Free PMC article.

5

The psychometric performance of generic preference-based measures for patients with pressure ulcers.

Palfreyman S, Mulhern B. Palfreyman S, et al. Among authors: mulhern b. Health Qual Life Outcomes. 2015 Aug 1;13:117. doi: 10.1186/s12955-015-0307-4. Health Qual Life Outcomes. 2015. PMID: 26231179 Free PMC article.

6

Comparing the measurement equivalence of EQ-5D-5L across different modes of administration.

Mulhern B, O'Gorman H, Rotherham N, Brazier J. Mulhern B, et al. Health Qual Life Outcomes. 2015 Nov 26;13:191. doi: 10.1186/s12955-015-0382-6. Health Qual Life Outcomes. 2015. PMID: 26612336 Free PMC article.

7

The Impact of Different DCE-Based Approaches When Anchoring Utility Scores.

Norman R, Mulhern B, Viney R. Norman R, et al. Among authors: mulhern b. Pharmacoeconomics. 2016 Aug;34(8):805-14. doi: 10.1007/s40273-016-0399-7. Pharmacoeconomics. 2016. PMID: 27034244

8

Using Discrete Choice Experiments with Duration to Model EQ-5D-5L Health State Preferences.

Mulhern B, Bansback N, Hole AR, Tsuchiya A. Mulhern B, et al. Med Decis Making. 2017 Apr;37(3):285-297. doi: 10.1177/0272989X16670616. Epub 2016 Sep 29. Med Decis Making. 2017. PMID: 27681988 Free article.

9

Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?

Mulhern B, Norman R, Lorgelly P, Lancsar E, Ratcliffe J, Brazier J, Viney R. Mulhern B, et al. Pharmacoeconomics. 2017 Apr;35(4):439-451. doi: 10.1007/s40273-016-0475-z. Pharmacoeconomics. 2017. PMID: 27873226 Clinical Trial.

10

Developing a dementia-specific health state classification system for a new preference-based instrument AD-5D.

Nguyen KH, Mulhern B, Kularatna S, Byrnes J, Moyle W, Comans T. Nguyen KH, et al. Among authors: mulhern b. Health Qual Life Outcomes. 2017 Jan 25;15(1):21. doi: 10.1186/s12955-017-0585-0. Health Qual Life Outcomes. 2017. PMID: 28122626 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters